CompletedPhase 3NCT01774474
PRevention of Macular EDema After Cataract Surgery
Studying Cystoid macular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Maastricht University Medical Center
- Principal Investigator
- prof. Rudy MM Nuijts, MD, PhDUniversity Eye Clinic Maastricht, University Hospital Maastricht
- Intervention
- Bromfenac(drug)
- Enrollment
- 1127 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2013 – 2016
Study locations (16)
- Vienna Institute for Research in Ocular Surgery, Hanusch Krankenhaus, Vienna, Austria
- Hospital of the Brothers of Saint John of God, Vienna, Austria
- University Hospital Antwerp, Edegem, Belgium
- Goethe University, Frankfurt am Main, Germany
- Semmelweis University, Budapest, Hungary
- VU University Medical Center, Amsterdam, Netherlands
- Academic Medical Center, Amsterdam, Netherlands
- Amphia Hospital Breda, Breda, Netherlands
- Zuyderland Medical Center, Heerlen, Netherlands
- Eye Hospital Zonnestraal, Hilversum, Netherlands
- University Eye Clinic Maastricht UMC+, Maastricht, Netherlands
- Medical Centre Haaglanden, The Hague, Netherlands
- St. Elisabeth Hospital, Tilburg, Netherlands
- Máxima Medical Center Veldhoven, Veldhoven, Netherlands
- University Hospital Coimbra, Coimbra, Portugal
- +1 more locations on ClinicalTrials.gov
Collaborators
European Society of Cataract and Refractive Surgeons
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01774474 on ClinicalTrials.govOther trials for Cystoid macular dystrophy
Additional recruiting or active studies for the same condition.